CPA4 is a novel biomarker for cancer that is prevalent in a variety of cancers and is recognized to regulate inflammation, playing an essential role in the tumor microenvironment as well as tumor cell proliferation and invasion [17,20–22]. This evidence concerns the gene CPA4 and neoplasm.